Rhythm Pharmaceuticals, Inc. Common Stock RYTM
$116.02
-1.34%
at last close
Analyst Consensus
- Consensus Rating
- Buy (13 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $144.00
- Implied Upside
- +24.1%
- Price Target Range
- $105.00 – $160.00
- Analysts (12 mo)
- 13
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | JP MorganPriyanka Grover |
Maintains | Overweight | $145 → $146 |
| 2026-08-05 | CitigroupSamantha Semenkow |
Maintains | Buy | $142 → $143 |
| 2026-08-05 | RBC CapitalLisa Walter |
Maintains | Outperform | $141 → $155 |
| 2026-08-05 | CitizensJonathan Wolleben |
Maintains | Market outperform | $155 → $160 |
| 2026-07-27 | JP MorganPriyanka Grover |
Initiates coverage on | Overweight | $145 |
| 2026-07-07 | RBC CapitalLisa Walter |
Maintains | Outperform | $137 → $141 |
| 2026-06-16 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $143 → $151 |
| 2026-06-15 | Wells FargoDerek Archila |
Maintains | Overweight | $144 → $155 |
| 2026-05-07 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $140 → $143 |
| 2026-05-06 | RBC CapitalLisa Walter |
Maintains | Outperform | $136 → $137 |
| 2026-05-06 | Wells FargoDerek Archila |
Maintains | Overweight | $143 → $144 |
| 2026-03-23 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $100 → $105 |
| 2026-03-20 | CitigroupSamantha Semenkow |
Maintains | Buy | $131 → $142 |
| 2026-03-20 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $139 → $149 |
| 2026-03-20 | CitizensJonathan Wolleben |
Maintains | Market outperform | $152 → $155 |
| 2026-03-18 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $110 → $100 |
| 2026-03-17 | CitigroupSamantha Semenkow |
Maintains | Buy | $136 → $131 |
| 2026-03-17 | RBC CapitalLisa Walter |
Maintains | Outperform | $140 → $130 |
| 2026-03-17 | CitizensJonathan Wolleben |
Maintains | Market outperform | $176 → $152 |
| 2026-03-17 | B of A SecuritiesTazeen Ahmad |
Maintains | Buy | $145 → $139 |
| 2026-03-17 | Morgan StanleyJeffrey Hung |
Maintains | Overweight | $150 → $136 |
| 2026-03-17 | NeedhamJoseph Stringer |
Maintains | Buy | $139 → $130 |
| 2026-03-12 | Wells FargoDerek Archila |
Maintains | Overweight | $136 → $143 |
| 2026-03-02 | Canaccord GenuityWhitney Ijem |
Maintains | Buy | $141 → $140 |
| 2026-03-02 | HC Wainwright & Co.Raghuram Selvaraju |
Maintains | Buy | $125 → $110 |
| 2026-02-27 | Wells FargoDerek Archila |
Maintains | Overweight | $145 → $136 |
| 2026-02-27 | CitizensJonathan Wolleben |
Maintains | Market outperform | $167 → $176 |
| 2026-02-27 | GuggenheimSeamus Fernandez |
Maintains | Buy | $140 → $143 |
| 2026-02-26 | NeedhamJoseph Stringer |
Maintains | Buy | $148 → $139 |
| 2026-02-19 | RBC CapitalLisa Walter |
Initiates coverage on | Outperform | $145 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $116.02
- Market Cap
- $8.10 billion
- 52-Week Range
- $74.50 – $122.20
- Average Volume
- 710K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.